Summary: Spire’s health platform and respiration sensor enables highly effective and low-cost remote monitoring for respiratory-related chronic diseases. The company’s patented respiration sensor collects accurate and continuous ambulatory respiratory data, which has been validated in peer-reviewed studies. The innovative “Health Tag” form factor eliminates the problem of patient adherence by making the sensor disappear — all a patient needs to do is wear their existing clothes. The Spire respiration sensor is a novel approach to respiration monitoring that measures the expansion and contraction of the thoracic cavity, capturing extremely rich and accurate respiration data. Spire has collected the world’s largest database of ambulatory respiration data, enabling continued optimization of Spire’s data algorithms. Spire’s Health Tag also captures heart rate, activity and sleep data, providing a broad view of a patient’s health. The Spire API provides partners with full access to Spire’s processed and raw data, enabling partners to build their own applications to target specific health conditions. Spire’s customers include Fortune 500 companies using Spire’s technology to lower costs and improve patient outcomes across asthma, COPD, sleep apnea, and anxiety. Last year the company generated $4.2M in revenue and is growing over 50% YoY with over 100k units sold.
Value: Spire enables a level of accurate, ambulatory and long-term respiration and health monitoring that hasn’t been possible before. Spire’s respiration sensor is capable of capturing extremely rich and accurate respiration data with a form factor that is nearly invisible to the user, creating extremely high patient adherence. Health providers can leverage the Spire platform to monitor a range of health conditions, including COPD, Asthma and CHF, and develop appropriate interventions that improve outcomes and reduce costs, including driving lower re-admission rates among discharged patients.